Immunoassay Market, By Product (Reagents & Kits, Analyzers and Others), By Technology, By Detection, By Specimen, By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
ANV6308
|
Published Date
November 2026
|
Pages
294
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Immunoassay market size was valued at US$ 29,807.3 Million in 2025, expanding at a CAGR of 7.3% from 2026 to 2033.
Immunoassay tests are special tests that are done in a laboratory setting and utilize binding of antibodies for detection and quantification of target molecules in samples such as blood, saliva, and urine, among others. This market includes the instruments, chemicals, and kits for the detection and quantification of antibodies, hormones, antigens, proteins, drugs, and disease markers. Immunoassay tests are commonly used by both researchers and doctors to determine infection, check for thyroid and cardiac activity, test cancer markers, help in fertility and pregnancy monitoring, and also in drug discovery. They are also highly sensitive and rapid, and hence, they can be easily conducted using automated analyzers. With continued technological advances, more multiplexed and automated systems have been developed. Therefore, immunoassay tests have become an important part of modern medicine.
Immunoassay Market- Market Dynamics
Increasing Adoption of Biomarker-Based Diagnosis to Accelerate Market Expansion
Increasing adoption of biomarker-based diagnosis has resulted in the increased need for advanced immunoassays technology. It makes it possible for healthcare professionals to detect biomarkers that are linked with certain diseases. This enhances the diagnosis process through making it more accurate and helping in diagnosing diseases early and personalizing treatment choices. For instance, in October 2025, The Daffodil Centre Org. conducted a systematic review synthesizing evidence from 77 global studies and revealed the rising significance of biomarker testing as an essential aspect in cancer care and precision medicine. This makes it possible to have personalized treatment because the genetic and tumor profiles of the patients can be identified. This review pointed out some improvements in the use of the biomarker test in the clinic, such as tumor boards within the institutes and multidisciplinary teams, continuous education for clinicians, patient-friendly resources, and digital tools.
Immunoassay Market- Segmentation Analysis:
The Global Immunoassay market is segmented on the basis of Product, Technology, Detection, Specimen, Application, End User, and Region.
In technology, chemiluminescence and electrochemiluminescence immunoassays hold a significant share of the immunoassay market. These assays have a high sensitivity, large measuring ranges, and rapid turnaround and can also be done using fully automated random access analyzers. This enables several tests, such as infectious disease tests, cardiac tests, oncology tests, endocrine tests, fertility tests, and neurological tests, to be performed on the same platform. The above features make these immunoassays suitable for busy hospitals and reference laboratories.
Roche companies have a strong presence in this segment with various assays that are found in their Cobas platforms and known as Elecsys. In May 2026, Roche obtained the CE Mark approval for Elecsys pTau217. This assay performs a blood-based test that helps in the ruling in or out of Alzheimer\'s amyloid pathology. It goes to show how the segment is growing and venturing into new applications. As high-sensitivity automated platforms continue to broaden the clinical application of immunoassays into advanced neurological diagnosis.
Immunoassay Market- Geographical Insights
North America holds a prominent share of the Immunoassay market, advanced laboratory infrastructure, wide use of automated chemiluminescence, positive reimbursement rates, and frequent disease testing. For instance, in August 2026, according to the Government of Canada, the government has received a $768.6 million construction services contract for the Regulatory and Security Science Main (RSS Main) project to advance modern science and laboratory infrastructure in Ottawa. The present project phase is worth about $1 billion or about 50% of its entire scope. The government campus has six high-end science buildings, which would accommodate around 275 employees in support of 25 science programs. This investment will bolster Canada\'s advanced clinical and public health laboratory infrastructure. Thus, investments in advanced laboratory infrastructure help North America maintain its major position in the Immunoassay market.
China Immunoassay Market - Country Insights
China is a major contributor to market growth as a result of an increase in infectious and chronic disease prevalence and an aging population in the country. For instance, in April 2026, according to the Journal of Global Health Org, mainland China had 51.77 million cases of infectious diseases, with a total of 38 infectious diseases. This represents an average of 734.89 per 100,000 people, demonstrating the increase in the number of infectious diseases. Respiratory infectious diseases made up 57.14% of the total number of reported cases, while 961.38 per 100,000 people reported respiratory infectious diseases because of the relaxation of the ban on COVID-19 infections. Moreover, 118,206 deaths were reported, revealing the increasing number of deaths from infectious diseases in China. This increase in infectious diseases in China is a key driver, as it increases the demand for advanced diagnostic tools.
Immunoassay Market- Competitive Landscape:
The Immunoassay market is quite competitive and major players include Roche, Abbott, Siemens Healthineers, Beckman Coulter and QuidelOrtho competing based on large menus, automation and global network services. They are working on innovative biomarkers such as Alzheimer’s and neurology and partnering with each other for expanding their menu in those areas that have not been covered by them yet. In February 2026 QuidelOrtho signed along-term supply partnership with Lifotronic Technology to broaden its portfolio of global immunoassays and utilize multiple platforms. Such initiatives will help them to improve their market standing.
Recent Developments:
- In April 2026, Beckman Coulter received CE Mark under IVDR for its Access MeMed BV immunoassay, a test that aids in identifying whether an infection is caused by bacteria or virus. Roche also received the CE Mark for its Elecsys NfL blood test that helps monitor neuroinflammation in patients with multiple sclerosis.
- In January 2026, Siemens Healthineers gained FDA clearance for their Atellica IM Total PSA II assay to monitor prostate cancer. Fujirebio launched the Lumipulse G pTau217 CSF assay for research purposes.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IMMUNOASSAY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Danaher Corporation
- Becton, Dickinson and Company
- Sysmex Corporation
- QIAGEN N.V.
- Agilent Technologies, Inc.
- Merck KGaA
- Hologic, Inc.
- Tosoh Corporation
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Randox Laboratories Ltd.
- Fujirebio Holdings, Inc.
- Mitra & Co. Pvt. Ltd.
- Quanterix Corporation
- Tecan Group AG
- Bio-Techne Corporation
- Enzo Biochem, Inc.
- Others
GLOBAL IMMUNOASSAY MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Reagents & Kits
- Analyzers
- Others
GLOBAL IMMUNOASSAY MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- ELISA
- CLIA
- Western Blotting
- Rapid Tests
- Others
GLOBAL IMMUNOASSAY MARKET, BY DETECTION- MARKET ANALYSIS, 2020 - 2033
- Colorimetric Immunoassays
- Radioimmunoassays
- Fluorescence Immunoassays
- Immunoturbidimetric & Nephelometric Immunoassays
- Others
GLOBAL IMMUNOASSAY MARKET, BY SPECIMEN- MARKET ANALYSIS, 2020 - 2033
- Blood
- Saliva
- Urine
- Others
GLOBAL IMMUNOASSAY MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Infectious Diseases
- Endocrinology
- Cardiology
- Oncology
- Allergy Diagnostics
- Blood Screening
- Bone and Mineral Disorders
- Newborn Screening
- Autoimmune Disorders
- Drug Monitoring and Testing
- Others
GLOBAL IMMUNOASSAY MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Home Care Settings
- Clinical Laboratories
- Blood Banks
- Others
GLOBAL IMMUNOASSAY MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
TABLE OF CONTENT
1. Immunoassay Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.2. Competitive Insights
3. Immunoassay Key Market Trends
3.1. Immunoassay Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Immunoassay Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Immunoassay Market Opportunities
3.4. Immunoassay Market Future Trends
4. Immunoassay Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Immunoassay Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Immunoassay Market Landscape
6.1. Immunoassay Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Immunoassay Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
7.1.2. Reagents & Kits
7.1.3. Analyzers
7.1.4. Others
8. Immunoassay Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
8.1.2. ELISA
8.1.3. CLIA
8.1.4. Western Blotting
8.1.5. Rapid Tests
8.1.6. Others
9. Immunoassay Market – By Detection
9.1. Overview
9.1.1. Segment Share Analysis, By Detection, 2025 & 2033 (%)
9.1.2. Colorimetric Immunoassays
9.1.3. Radioimmunoassays
9.1.4. Fluorescence Immunoassays
9.1.5. Immunoturbidimetric & Nephelometric Immunoassays
9.1.6. Others
10. Immunoassay Market – By Specimen
10.1. Overview
10.1.1. Segment Share Analysis, By Specimen, 2025 & 2033 (%)
10.1.2. Blood
10.1.3. Saliva
10.1.4. Urine
10.1.5. Others
11. Immunoassay Market – By Application
11.1. Overview
11.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
11.1.2. Infectious Diseases
11.1.3. Endocrinology
11.1.4. Cardiology
11.1.5. Oncology
11.1.6. Allergy Diagnostics
11.1.7. Blood Screening
11.1.8. Bone and Mineral Disorders
11.1.9. Newborn Screening
11.1.10. Autoimmune Disorders
11.1.11. Drug Monitoring and Testing
11.1.12. Others
12. Immunoassay Market – By End User
12.1. Overview
12.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
12.1.2. Hospitals
12.1.3. Home Care Settings
12.1.4. Clinical Laboratories
12.1.5. Blood Banks
12.1.6. Others
13. Immunoassay Market – By Geography
13.1. Introduction
13.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
13.2. North America
13.2.1. Overview
13.2.2. Immunoassay Key Manufacturers in North America
13.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.2.4. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
13.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
13.2.6. North America Market Size and Forecast, By Detection, 2020 - 2033 (US$ Million)
13.2.7. North America Market Size and Forecast, By Specimen, 2020 - 2033 (US$ Million)
13.2.8. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13.2.9. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.2.10. U.S.
13.2.11. Canada
13.3. Europe
13.3.1. Overview
13.3.2. Immunoassay Key Manufacturers in Europe
13.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.3.4. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
13.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
13.3.6. Europe Market Size and Forecast, By Detection, 2020 - 2033 (US$ Million)
13.3.7. Europe Market Size and Forecast, By Specimen, 2020 - 2033 (US$ Million)
13.3.8. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13.3.9. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.3.10. Germany
13.3.11. UK
13.3.12. France
13.3.13. Italy
13.3.14. Spain
13.3.15. The Netherlands
13.3.16. Sweden
13.3.17. Russia
13.3.18. Poland
13.3.19. Denmark
13.3.20. Rest of Europe
13.4. Asia Pacific (APAC)
13.4.1. Overview
13.4.2. Immunoassay Key Manufacturers in Asia Pacific
13.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.4.4. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
13.4.5. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
13.4.6. APAC Market Size and Forecast, By Detection, 2020 - 2033 (US$ Million)
13.4.7. APAC Market Size and Forecast, By Specimen, 2020 - 2033 (US$ Million)
13.4.8. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13.4.9. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.4.10. China
13.4.11. India
13.4.12. Japan
13.4.13. South Korea
13.4.14. Australia
13.4.15. Indonesia
13.4.16. Thailand
13.4.17. Philippines
13.4.18. Taiwan
13.4.19. Vietnam
13.4.20. Rest of APAC
13.5. Latin America (LATAM)
13.5.1. Overview
13.5.2. Immunoassay Key Manufacturers in Latin America
13.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.5.4. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
13.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
13.5.6. LATAM Market Size and Forecast, By Detection, 2020 - 2033 (US$ Million)
13.5.7. LATAM Market Size and Forecast, By Specimen, 2020 - 2033 (US$ Million)
13.5.8. LATAM Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13.5.9. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.5.10. Brazil
13.5.11. Mexico
13.5.12. Argentina
13.5.13. Colombia
13.5.14. Rest of LATAM
13.6. Middle East and Africa
13.6.1. Overview
13.6.2. Immunoassay Key Manufacturers in Middle East and Africa
13.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.6.4. Middle East and Africa Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
13.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
13.6.6. Middle East and Africa Market Size and Forecast, By Detection, 2020 - 2033 (US$ Million)
13.6.7. Middle East and Africa Market Size and Forecast, By Specimen, 2020 - 2033 (US$ Million)
13.6.8. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13.6.9. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.6.10. Saudi Arabia
13.6.11. UAE
13.6.12. Israel
13.6.13. Turkey
13.6.14. Algeria
13.6.15. Egypt
13.6.16. Iran
13.6.17. Qatar
13.6.18. Rest of MEA
14. Key Vendor Analysis- Immunoassay Industry
14.1. Competitive Benchmarking
14.1.1. Competitive Dashboard
14.1.2. Competitive Positioning
14.2. Company Profiles
14.2.1. Danaher Corporation
14.2.2. Becton, Dickinson and Company
14.2.3. Sysmex Corporation
14.2.4. QIAGEN N.V.
14.2.5. Agilent Technologies, Inc.
14.2.6. Merck KGaA
14.2.7. Hologic, Inc.
14.2.8. Tosoh Corporation
14.2.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
14.2.10. Randox Laboratories Ltd.
14.2.11. Fujirebio Holdings, Inc.
14.2.12. J. Mitra & Co. Pvt. Ltd.
14.2.13. Quanterix Corporation
14.2.14. Tecan Group AG
14.2.15. Bio-Techne Corporation
14.2.16. Enzo Biochem, Inc.
14.2.17. Others
15. 360 Degree AnalystView
16. Appendix
16.1. Research Methodology
16.2. References
16.3. Abbreviations
16.4. Disclaimer
16.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IMMUNOASSAY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Danaher Corporation
- Becton, Dickinson and Company
- Sysmex Corporation
- QIAGEN N.V.
- Agilent Technologies, Inc.
- Merck KGaA
- Hologic, Inc.
- Tosoh Corporation
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Randox Laboratories Ltd.
- Fujirebio Holdings, Inc.
- Mitra & Co. Pvt. Ltd.
- Quanterix Corporation
- Tecan Group AG
- Bio-Techne Corporation
- Enzo Biochem, Inc.
- Others
GLOBAL IMMUNOASSAY MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Reagents & Kits
- Analyzers
- Others
GLOBAL IMMUNOASSAY MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- ELISA
- CLIA
- Western Blotting
- Rapid Tests
- Others
GLOBAL IMMUNOASSAY MARKET, BY DETECTION- MARKET ANALYSIS, 2020 - 2033
- Colorimetric Immunoassays
- Radioimmunoassays
- Fluorescence Immunoassays
- Immunoturbidimetric & Nephelometric Immunoassays
- Others
GLOBAL IMMUNOASSAY MARKET, BY SPECIMEN- MARKET ANALYSIS, 2020 - 2033
- Blood
- Saliva
- Urine
- Others
GLOBAL IMMUNOASSAY MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Infectious Diseases
- Endocrinology
- Cardiology
- Oncology
- Allergy Diagnostics
- Blood Screening
- Bone and Mineral Disorders
- Newborn Screening
- Autoimmune Disorders
- Drug Monitoring and Testing
- Others
GLOBAL IMMUNOASSAY MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Home Care Settings
- Clinical Laboratories
- Blood Banks
- Others
GLOBAL IMMUNOASSAY MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Analystview Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
